SCHEMBL8283271

SCHEMBL8283271

CC1CCC(=O)N1N

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL2520252 0.98 — —
SCHEMBL16424925 0.86 — —
SCHEMBL16772259 0.74 — —
SCHEMBL13626381 0.72 — —
SCHEMBL262126 0.72 — —
SCHEMBL2302701 0.72 — —
SCHEMBL23692529 0.70 — —
SCHEMBL15214691 0.70 — —
SCHEMBL12532748 0.70 — —
SCHEMBL13948664 0.70 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024116207-A1 ADAR1 INHIBITORS AND METHODS OF USING THE SAME AVAMMUNE THERAPEUTICS INC. (IN) 2024-06-06 — — WO disclosed
US-20230338375-A1 SUBSTITUTED PYRIDAZINONES FOR USE IN THE TREATMENT OF NEUROMUSCULAR DISEASES EDGEWISE THERAPEUTICS, INC. 2023-10-26 — — US disclosed
EP-2804851-B1 LACTAM DERIVATES USEFUL AS INHIBITORS OF MUTANT IDH1 AGIOS PHARMACEUTICALS INC (US) 2018-07-18 — — EP disclosed
EP-3046156-A1 ORGANIC ELECTROLUMINESCENT ELEMENT, AND ILLUMINATION DEVICE AND DISPLAY DEVICE EACH COMPRISING THE ELEMENT Konica Minolta Holdings, Inc. (JP) 2016-07-20 — — EP disclosed
EP-2208726-A1 Cyclic amide derivatives, and their production and use as antithrombotic agents Takeda Pharmaceutical Company Limited (JP) 2010-07-21 — — EP disclosed
WO-2005113504-A1 CYCLIC AMIDE DERIVATIVES, AND THEIR PRODUCTION AND USE AS ANTITHROMBOTIC AGENTS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2005-12-01 — — WO disclosed
Send feedback